With reference to our intimation dated December 23, 2024 and January 22, 2025 we wish to inform to the Exchange that the said transaction as mentioned in the above intimation for proposed acquisition of 51% of the total issued and paid up share capital of TRIDENT MEDIQUIP LIMITED (CIN: U33309GJ2019PLC110421) from existing shareholders of the Company and making it a subsidiary company has been completed on February 04, 2025 at 09:32 a.m.